Tricuspid Valve Is Transcriptionally Active During Prolonged Pressure Overload, Right-Sided Heart Failure, and Valve Regurgitation.
Document Type
Article
Publication Date
2-3-2026
Publication Title
Journal of the American Heart Association
Abstract
BACKGROUND: Right-sided heart failure (RHF), in the presence of tricuspid valve regurgitation, results from left-sided heart failure, pulmonary hypertension (PH), or heart malformations. The occurrence of RHF and tricuspid regurgitation represents a critical indicator of hospitalization rates and all-cause mortality. However, RHF has remained understudied, specifically with respect to the tricuspid valve.
METHODS: Using the outbred sheep (
RESULTS: The de novo sheep heart transcriptome enhanced transcript mapping of reads by 43% to 45% in the heart valves relative to the reference transcriptome. Identified transcripts produce validated tissue-specific pathways in ventricles (2756 isoforms), pulmonary arteries (535 isoforms), and valves (1215 isoforms), with transcript differences between the mitral and tricuspid valve involved in extracellular and endocrine signaling. Pulmonary artery banding resulted in the most significant transcriptional changes in the tricuspid valve with alterations in endocrine and immune pathway genes.
CONCLUSIONS: This project highlights the complexity of heart valve tissues and their transcriptional activity in a sheep model of RHF. It suggests potential therapeutic interventions in heart valve remodeling in pulmonary artery hypertension, RHF, and tricuspid regurgitation. This work highlights the need for further human and model organism research into the dynamic valve cells and genes.
Volume
15
Issue
3
First Page
e046137
Last Page
e046137
Recommended Citation
Goodyke A, Gaweda B, Piekarska M, Arora S, Westgate M, Loyaga‐Rendon R, et al [Jani M, Prokop JW, Timek TA]. Tricuspid valve is transcriptionally active during prolonged pressure overload, right‐sided heart failure, and valve regurgitation. J Am Heart Assoc. 2026;15(3):e046137. doi: 10.1161/jaha.125.046137. PMID: 41614292.
DOI
10.1161/JAHA.125.046137
ISSN
2047-9980
PubMed ID
41614292
Comments
Frederik Meijer Heart & Vascular Institute